Braskem (BRKM5) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
9 Jul, 2026Executive summary
Recurring EBITDA reached US$224 million in Q1 2025, up 121% from Q4 2024, with net income of US$113 million and net profit attributable to shareholders of R$698 million, reversing prior losses.
Operations improved across all petrochemical plants, with higher utilization rates in all regions and a global accident frequency rate of 0.92 per million hours worked.
Strategic milestones included the inauguration of the ethane import terminal in Mexico and a capacity review for the green ethylene plant.
Net revenue was R$19,460 million, up 8.6% year-over-year, with gross profit at R$1,310 million.
Announced new investments in production capacity and transformation strategy in Brazil.
Financial highlights
Recurring EBITDA: US$224 million, up 121% quarter-over-quarter; EBITDA margin improved to 11%.
Net profit: US$113 million attributable to shareholders; net income at R$698 million.
Cash position: US$2 billion, covering debt maturities for the next 33 months, plus a US$1 billion undrawn credit line.
Corporate leverage at 7.92x at Q1 2025 end; net debt at US$6.6 billion, average maturity 9 years, 68% maturing from 2030.
Operating cash consumption: R$936 million, mainly due to working capital changes and scheduled shutdowns.
Outlook and guidance
Mixed scenario expected in Q2 2025: higher utilization in Brazil and US, stable US/Europe, lower production in Mexico due to a 45-day shutdown.
International spreads remain challenging; lower nafta prices may benefit resin spreads in Brazil, while higher ethane prices could pressure gas-based PE spreads.
Strategic investments include capacity expansions and sustainability projects, with R$614 million in new projects announced.
Company focuses on resilience, financial health, and transformation, with ongoing cost reductions and asset optimization.
Latest events from Braskem
- EBITDA surged 104% sequentially, but net loss and high leverage persisted amid legal and market headwinds.BRKM5
Q3 20259 Jul 2026 - EBITDA surged 39–46%, but net loss widened on currency impacts; liquidity remains strong.BRKM5
Q2 20248 Jul 2026 - Recurring EBITDA fell 49% and net loss reached R$10,961m amid high leverage and industry downturn.BRKM5
Q4 20258 Jul 2026 - EBITDA rose 76% sequentially, but leverage, cash burn, and legal risks remain high.BRKM5
Q1 20267 Jul 2026 - EBITDA plunged 67%, leverage hit 10.59x, and legal, market, and cash flow risks remain.BRKM5
Q2 20257 Jul 2026 - EBITDA up 46% to US$1.1B, but FX losses led to a net loss; strong liquidity and green focus.BRKM5
Q4 20243 Jul 2026 - EBITDA hit a two-year high on margin gains, but legal and currency risks remain.BRKM5
Q3 20243 Jul 2026 - 2030 targets: 1M tons each of bio-based and recycled products, with ambitious decarbonization goals.BRKM5
Investor Day 202412 Jan 2026